Vital Nutrients Ultra Pure Fish Oil 700 (softgel capsules) (Lemon Flavour) (Pharmaceutical Grade)

Vital Nutrients Ultra Pure Fish Oil 700 (120 softgel capsules) (Lemon Flavour) (Pharmaceutical Grade) - supplement facts.JPG
Vital Nutrients Ultra Pure Fish Oil 700 (60 softgel capsules) (Lemon Flavour).jpg
Vital Nutrients Ultra Pure Fish Oil 700 Enteric coated (90 capsules).jpg
Vital Nutrients Ultra Pure Fish Oil 700 (120 softgel capsules) (Lemon Flavour) (Pharmaceutical Grade) - supplement facts.JPG
Vital Nutrients Ultra Pure Fish Oil 700 (60 softgel capsules) (Lemon Flavour).jpg
Vital Nutrients Ultra Pure Fish Oil 700 Enteric coated (90 capsules).jpg

Vital Nutrients Ultra Pure Fish Oil 700 (softgel capsules) (Lemon Flavour) (Pharmaceutical Grade)


High-Potency Deep Sea Fish Oil, Cardiovascular Support

Add To Cart

Ultra Pure Fish Oil, with 360 mg EPA and 240 mg DHA per capsule, is formulated to provide a higher concentration of EPA and DHA per softgel — double that of standard products. The other product feature is the purity of the Vital Nutrients pharmaceutical-grade fish oil.


Fish oil helps protect and maintain the normal function, fluidity, and health of cell membranes. EPA and DHA help maintain and support soft tissue and connective tissue. They are necessary for normal inflammation levels and protect cardiovascular, joint, kidney, and brain tissues from degeneration otherwise caused by uncontrolled inflammation (Kidd 2007). There appears to be a very special relationship between DHA and nerve tissue. A deficiency of DHA leads to delayed neural development and is associated with Alzheimer's disease and ADHD (Kidd, 2007).


Fish oil helps relieve mild mood changes and cramps associated with the menstrual cycle (Kris-Etherton, Harris & Appel, 2003). The mind and mood benefits of EPA that have been proven in studies include significant reduction in depression and aggression scores (Kidd, 2007).


There is a considerable body of evidence showing that increased intake of EPA and DHA decreases the risk of cardiovascular disease (Marchioli et al., 2002) by 1) preventing arrhythmias that can lead to sudden cardiac death; 2) decreasing the risk of thrombosis that can lead to myocardial infarction or stroke; 3) decreasing serum triglyceride levels; 4) slowing the growth of atherosclerotic plaque; 5) improving vascular endothelial function; 6) lowering blood pressure slightly; and 7) decreasing inflammation (Kris-Etherton, Harris & Appel, 2003).


Several studies show that fish oil supplementation significantly reduces mortality from cardiovascular events. In the largest randomized controlled trial of supplemental omega-3 fatty acids to date, coronary heart disease patients who received supplements providing 850 mg/day of EPA + DHA for 3.5 years had a 45% lower risk of sudden death than those who did not take supplements. Supplement users also experienced a 20% lower risk of death from all causes compared to non-supplement users (Kris-Etherton, Harris & Appel, 2003).


Interestingly, it took only three months of supplementation to demonstrate a significant decrease in total mortality and just four months to demonstrate a significant decrease in sudden death (Kris-Etherton, Harris & Appel, 2003).


Ultra Pure Fish Oil 360/240 softgels have a pleasant natural lemon flavour.


Recommended Dosage:

1 to 2 capsules 2 to 3 times a day with food or as directed by your healthcare professional.


Astarita, G., et al., 2010. Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PloS ONE, 5(9), e12538. PMID: 20838618.


Broughton, K.S., et al., 1997. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. The American Journal of Clinical Nutrition, 65(4), 1011-1017. PMID: 9094887


Crawford, M., 1995. Nutrition and evolution, New Canaan  Conn.: Keats Pub.


Francois, C.A., et al., 2003. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. The American Journal of Clinical Nutrition, 77(1), 226-233. PMID: 12499346.


Gleissman, H. et al., 2011. Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo. International Journal of Cancer,128(7):1703-11. PMID: 20499314.


Goldberg, R.J. & Katz, J., 2007. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 129(1-2), 210-223. PMID: 17335973.


Helland, I.B., et al., 2003. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics, 111(1), e39-44. PMID: 12509593.


Hodge, L., et al., 1996. Consumption of oily fish and childhood asthma risk. The Medical Journal of Australia, 164(3), 137-140. PMID: 8628130


Kelavkar, U.P., et al., 2006. Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia, 8(2), 112-124. PMID: 16611404.


Kidd, P.M., 2007. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Alternative Medicine Review, 12(3), 207-227. PMID: 18072818


Kim, J., et al., 2009. Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study. BMC Cancer, 9, 216. PMID: 19566923.


Kris-Etherton, P.M., Harris, W.S. & Appel, L.J., 2003. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(2), 151-152. PMID: 12588750.


Lavie, C.J., et al., 2009. Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases. Journal of the American College of Cardiology, 54(7), 585-594.


Manna, S., et al., 2008. Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7,12-dimethylbenz(alpha)anthracene-induced mammary carcinogenesis in rats. Prostaglandins, Leukotrienes and Essential Fatty Acids, 79(1-2), 5-14. PMID: 18614344.


Marchioli, R., et al., 2002. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation, 105(16), 1897-1903. PMID: 11997274.


Mas, E., et al., 2010. The omega-3 fatty acids EPA and DHA decrease plasma F2-isoprostanes: Results from two placebo-controlled interventions. Free Radical Research, 44(9), 983-990.

Prescott, S.L. & Calder, P.C., 2004. N-3 polyunsaturated fatty acids and allergic disease. Currrent Opinion in Clinical Nutrition & Metabolic Care, 7(2), 123-129. PMID: 15075701.


Ramos, E.J.B., et al., 2004. Effects of omega-3 fatty acid supplementation on tumor-bearing rats. Journal of the American College of Surgeons, 199(5), 716-723. PMID: 15501111.


Richardson, A.J., 2006. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. International Review of Psychiatry, 18(2), 155-172. PMID: 16777670.


Richardson, A.J. & Montgomery, P., 2005. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics, 115(5), 1360-1366. PMID: 15867048.


Simopoulos, A.P., 1999. Essential fatty acids in health and chronic disease. The American Journal of Clinical Nutrition, 70(3 Suppl), 560S-569S. PMID: 10479232.


Strannegård, O. & Strannegård, I.L., 2001. The causes of the increasing prevalence of allergy: is atopy a microbial deprivation disorder? Allergy, 56(2), 91-102. PMID: 11167368.


Toriyama-Baba, H., et al., 2001. Organotropic chemopreventive effects of n-3 unsaturated fatty acids in a rat multi-organ carcinogenesis model. Japanese Journal of Cancer Research, 92(11), 1175-1183. PMID: 11714441.


Uauy, R., et al., 2001. Essential fatty acids in visual and brain development. Lipids, 36(9), 885-895. PMID: 11724460